Rabbit Polyclonal Sulfatase 1/SULF1 antibody. Suitable for IHC-P and reacts with Human samples. Cited in 11 publications.
View Alternative Names
KIAA1077, SULF1, Extracellular sulfatase Sulf-1, hSulf-1, Arylsulfatase, N-acetylglucosamine-6-sulfatase
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Sulfatase 1/SULF1 antibody (AB32763)
IHC image of Sulfatase 1/SULF1 staining in Human skeletal muscle formalin-fixed paraffin embedded tissue section*, performed on a Leica Bond™ system.. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab32763, 0.1 μg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
*Tissue obtained from the Human Research Tissue Bank, supported by the NIHR Cambridge Biomedical Research Centre
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
SULF1 plays a significant role in modulating cellular processes like growth angiogenesis and tissue repair by altering the bioavailability of heparan sulfate-bound signaling molecules. It often acts as a monomer but may participate in larger complexes during functional modulation. SULF1 regulates interactions with key growth factors such as fibroblast growth factors (FGFs) and vascular endothelial growth factors (VEGFs) impacting cell communication and migration.
Pathways
SULF1 is an important regulator in signaling pathways including the VEGF signaling pathway and the FGF signaling pathway. These pathways are essential for processes like angiogenesis and embryonic development. SULF1 activity influences these pathways by modifying heparan sulfate chains affecting the binding of FGFs and VEGFs to their respective receptors alongside related proteins like SULF2 which shares similar functions in these pathways.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (11)
Recent publications for all applications. Explore the full list and refine your search
Cancer science 116:2774-2787 PubMed40706632
2025
Applications
Unspecified application
Species
Unspecified reactive species
eLife 12: PubMed36622753
2023
Applications
Unspecified application
Species
Unspecified reactive species
Arteriosclerosis, thrombosis, and vascular biology 41:1408-1427 PubMed33626908
2021
Applications
Unspecified application
Species
Unspecified reactive species
International journal of oncology 57:223-236 PubMed32377705
2020
Applications
Unspecified application
Species
Unspecified reactive species
Toxicology and applied pharmacology 348:43-53 PubMed29673857
2018
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 7:13847 PubMed29062064
2017
Applications
Unspecified application
Species
Unspecified reactive species
Journal of neurochemistry 142:534-544 PubMed28547849
2017
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 9:e93711 PubMed24690739
2014
Applications
WB
Species
Human
PloS one 6:e23274 PubMed21853101
2011
Applications
Unspecified application
Species
Unspecified reactive species
Proceedings of the National Academy of Sciences of 107:10202-7 PubMed20479257
2010
Applications
WB
Species
Human
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com